Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
ANTENGENE-B (06996) founders, CEO, chairman and other management increased their holdings.
CEOVU (00798) will distribute a final dividend of HK $0.0049 per share on October 30th.
HESAI-W(02525) issued a total of 785,400 rewards.
ANTENGENE-B (06996) founders, CEO, chairman and other management increased their holdings.
CEOVU (00798) will distribute a final dividend of HK $0.0049 per share on October 30th.
HESAI-W(02525) issued a total of 785,400 rewards.
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026
